Erding Hu
Department of Vascular Biology
GlaxoSmithKline
Rm. 25-1084
709 Swedeland Road
USA
Name/email consistency: high
- Identification of novel isoform-selective inhibitors within class I histone deacetylases. Hu, E., Dul, E., Sung, C.M., Chen, Z., Kirkpatrick, R., Zhang, G.F., Johanson, K., Liu, R., Lago, A., Hofmann, G., Macarron, R., de los Frailes, M., Perez, P., Krawiec, J., Winkler, J., Jaye, M. J. Pharmacol. Exp. Ther. (2003)
- Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases. Hu, E., Lee, D. Curr. Opin. Investig. Drugs (2003)